Content type
Domains
Industry
Compliance Framework
- Reset
- 3 results found
- (-) HIPAA
- (-) Internal Network
Pharma Pen Testing: Why FDA and IP Risk Need Different Scoping
Standard pen test scoping frameworks weren't built for pharma. Learn how to scope an engagement that covers validated systems under 21 CFR Part 11 and protects high-value formulation and clinical data from targeted threats.
Pharmaceutical Pen Testing: What 21 CFR Part 11 and cGMP Require
21 CFR Part 11 and cGMP don't mention penetration testing but the controls they require depend on it. Learn how to align your pharma pen test program with regulatory requirements and prepare for FDA data integrity inspections.
Pharmaceutical Pen Testing: Why R&D and GxP Need Different Scopes
R&D and GxP regulated environments have different risk profiles, compliance requirements, and testing constraints. Learn why a single unified pen test scope fails both and how to run dual-scope engagements efficiently.